Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study
- PMID: 33778945
- PMCID: PMC9292145
- DOI: 10.1111/jcpp.13419
Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study
Abstract
Background: Methylphenidate may improve executive functioning in children with attention-deficit/hyperactivity disorder (ADHD). However, it is unclear if there are still acute effects of methylphenidate on executive functioning after long-term use.
Methods: In a randomized double-blind, placebo-controlled discontinuation study, 94 children and adolescents (ages 8-18 years) who used methylphenidate beyond two years were either assigned to seven weeks of continued treatment with 36 or 54 mg of extended-release methylphenidate or to gradual withdrawal over three weeks to placebo for four weeks. Performance on neuropsychological tasks, measuring working memory, response inhibition, attentional flexibility and psychomotor speed was compared between both groups using mixed models for repeated measures. Additionally, we investigated within the discontinuation group if a deterioration on the investigator-rated Clinical Global Impressions Improvement scale after withdrawing to placebo was related to a worse performance on the neuropsychological tasks. This study was registered in the Netherlands Trial Register (www. Trialregister.nl) with identifier 5252.
Results: After withdrawal of methylphenidate, the discontinuation group made more errors on working memory (β = -1.62, SD = 0.56, t = -2.88, p = .01, Cohen's f2 = .14), independent from reaction time compared to baseline, in contrast to the continuation group. We did not find differences in changes in response inhibition, attentional flexibility and psychomotor speed between the two groups. Also, there were no significant differences in task measures between the participants who deteriorated clinically and those who did not.
Conclusions: Our study shows that methylphenidate has a beneficial effect on working memory after two years of use. Future studies should explore whether cognitive outcomes may aid clinical decision-making on the continued use of methylphenidate, given dissociation between cognitive and behavioural effects of stimulant medication.
Keywords: attention-deficit/hyperactivity disorder; executive functioning; long-term; methylphenidate; working memory.
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
Figures
Similar articles
-
Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study.Am J Psychiatry. 2019 Sep 1;176(9):754-762. doi: 10.1176/appi.ajp.2019.18111296. Epub 2019 May 21. Am J Psychiatry. 2019. PMID: 31109200 Clinical Trial.
-
OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.Eur Neuropsychopharmacol. 2014 Apr;24(4):519-28. doi: 10.1016/j.euroneuro.2014.01.007. Epub 2014 Jan 18. Eur Neuropsychopharmacol. 2014. PMID: 24508533 Clinical Trial.
-
Withdrawing methylphenidate in relation to serum levels of ferritin and zinc in children and adolescents with attention-deficit/hyperactivity disorder.J Psychiatr Res. 2022 Aug;152:31-37. doi: 10.1016/j.jpsychires.2022.06.014. Epub 2022 Jun 9. J Psychiatr Res. 2022. PMID: 35714551 Clinical Trial.
-
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.J Child Psychol Psychiatry. 2021 Jun;62(6):680-700. doi: 10.1111/jcpp.13305. Epub 2020 Aug 26. J Child Psychol Psychiatry. 2021. PMID: 32845025
-
Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Paediatr Drugs. 2009. PMID: 19445548 Review.
Cited by
-
Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series.Children (Basel). 2024 Feb 2;11(2):187. doi: 10.3390/children11020187. Children (Basel). 2024. PMID: 38397299 Free PMC article.
-
Efficacy of Cognitive Behavioral Therapy and Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: A Systematic Review.Cureus. 2022 Dec 17;14(12):e32647. doi: 10.7759/cureus.32647. eCollection 2022 Dec. Cureus. 2022. PMID: 36660538 Free PMC article. Review.
-
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review.J Pers Med. 2023 Mar 23;13(4):574. doi: 10.3390/jpm13040574. J Pers Med. 2023. PMID: 37108960 Free PMC article. Review.
-
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844168 Free PMC article.
-
Neural markers of methylphenidate response in children with attention deficit hyperactivity disorder and the impact on executive function.Front Psychiatry. 2025 Mar 13;16:1475889. doi: 10.3389/fpsyt.2025.1475889. eCollection 2025. Front Psychiatry. 2025. PMID: 40182201 Free PMC article.
References
-
- Abikoff, H. , Hechtman, L. , Klein, R.G. , Gallagher, R. , Fleiss, K. , Etcovitch, J. , … & Pollack, S. (2004). Social functioning in children with ADHD treated with long‐term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 820–829. - PubMed
-
- Akaike, H. (1973). Information theory and an extension of the maximum likelihood principle. Second International Symposium on Information Theory (Tsahkadsor, 1971). Available from http://search.ebscohost.com.proxy‐ub.rug.nl/login.aspx?direct=true&db=ms...
-
- Bolfer, C. , Carreira, W.S. , Tsunemi, M.H. , Pacheco, S.P. , Casella, B.B. , & Casella, E.B. (2017). Attention‐deficit/hyperactivity disorder: The impact of methylphenidate on working memory, inhibition capacity and mental flexibility. Arquivos de Neuro‐Psiquiatria, 75, 204–208. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous